Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2013 Aug;57(8):4077–4078. doi: 10.1128/AAC.02376-12

First Description of KPC-2-Producing Klebsiella oxytoca in Brazil

Anna C S Almeida a,b,, Felipe L S Cavalcanti a,b, Willames M B Martins a,d, Marinalda A Vilela a, Ana C Gales c, Marcos A Morais Junior b, Márcia M C Morais a,*
PMCID: PMC3719734  PMID: 23752512

Abstract

The present work reports the detection of the first case of nosocomial Klebsiella oxytoca producing class A carbapenemase KPC-2 in Brazil. The isolate KPN106 carried a 65-kb IncW-type plasmid that harbors the blaKPC gene and Tn4401b. Moreover, we detected the presence of a class 1 integron containing a new allele, arr-8, followed by a 5′-truncated dhfrIIIc gene. In view of the recent results, we emphasize the high variability of the bacterial and genetic hosts of this resistance determinant.

TEXT

Despite the KPC enzymes being frequently associated with several members of the Enterobacteriaceae family, few reports have described the presence of KPC in Klebsiella oxytoca isolates (1). This work reports the first case of a KPC-2-producing K. oxytoca isolate in Brazil and describes its clinical data, susceptibility profile, and molecular analysis.

A 79-year-old female patient with chronic obstructive pulmonary disease and chronic renal failure was readmitted to the intensive care unit (ICU) at the University Hospital Oswaldo Cruz, Recife, Brazil, in December 2008. Due to her prior hospitalization (41 days), the patient received upon admission imipenem (250 mg every 6 h for 2 days) and polymyxin B (500,000 U every 12 h for 8 days). Blood cultures revealed the presence of a carbapenem-resistant K. oxytoca isolate (KPN106). The treatment with polymyxin B was maintained in combination with ciprofloxacin (400 mg every 12 h) for 7 days. The blood cultures remained positive after antimicrobial therapy. On the 12th day of her stay, the patient died with a diagnosis of renal and respiratory failure and sepsis. Here, we describe the microbiological and molecular analysis of this isolate.

Broth microdilution showed that the KPN106 isolate was highly resistant to most of the antimicrobial agents tested (Table 1) according to the CLSI standard (2). The isolate was tested for the presence of the class 1 integron, the extended-spectrum β-lactamase (ESBL), and class A and B carbapenemases.

Table 1.

Phenotypic and genetic characteristics of the bacterial strains used in this work

Straina β-Lactamase/class 1 integron cassette array MIC (μg/ml)b
AMK GEN CEF CRO CAZ FEP ATM IPM MEM ETP CIP TZP AMC RIF PMB TGC
KPN106 blaKPC-2, blaCTX-M-2, blaSHV-11, blaTEM-1, arr-8, dhfrIIIc 16 32 ≥256 ≥64 ≥64 8 128 ≥16 ≥16 ≥8 ≥8 ≥256 128 ≥8 0,25 1
TF106 blaKPC-2, arr-8, dhfrIIIc 16 0.25 64 >64 >64 8 128 >16 >16 >8 0.25 >128 32 0.25 0.25 0.03
DH5α None 0.12 0.25 8 0.06 0.5 0.5 0.5 0.12 <0.015 0.003 0.004 <2 <1 0.03 <0.12 0.06
a

KPN106, K. oxytoca isolate; TF106, E. coli transformant KPN106; DH5α, E. coli recipient strain.

b

AMK, amikacin; GEN, gentamicin; CEF, cephalothin; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; IPM, imipenem; MEM, meropenem; ETP, ertapenem; CIP, ciprofloxacin; TZP, piperacillin-tazobactam; AMC, amoxicillin-clavulanate; RIF, rifampin; PMB, polymyxin B; TGC, tigecycline.

Molecular analysis was carried out as described previously (3). In addition to blaKPC-2, KPN106 presented a class 1 integron and additional bla genes (Table 1). Moreover, it carried three plasmids (ca. 65 kb, 15 kb, and 12 kb) that were transferable to E. coli DH5α cells by calcium chloride transformation. The sequencing of the variable region of the class 1 integron revealed a new allele of the ADP ribosyltransferase family that confers rifampin resistance, arr-8 (GenBank accession number KC199968), with 75% protein similarity with the enzymes encoded by arr-2 and arr-3 alleles. Furthermore, we found a 5′-truncated form of the dhfrIIIc gene that encodes dihydrofolate dehydrogenase, followed by a partial putative insertion sequence. The Escherichia coli DH5α cells (TF106) selected on LB agar plates containing 100 μg/ml ampicillin acquired the 65-kb plasmid together with the blaKPC-2 gene and class 1 integron as shown by PCR. The plasmid incompatibility groups were determined as described previously (4), which demonstrated that these plasmids belong to the IncW group in both donor and transformant cells. This acquisition increased MICs of E. coli DH5α cells for extended-spectrum cephalosporins, carbapenems, and rifampin (Table 1). Analysis of the genetic environment (5) of blaKPC revealed the presence of the transposon Tn4401b isoform, as observed in a KPC-producing K. oxytoca isolate (1) and in other Enterobacteriaceae members (5).

Recently, there was reported the presence at the same hospital of a 65-kb IncW-type plasmid carrying blaKPC in Tn4401c among Enterobacteriaceae species (6). In the present study, we report a 65-kb IncW-type plasmid carrying blaKPC in Tn4401b in a K. oxytoca isolate, highlighting the diversity of mobile genetic elements related to the blaKPC gene in this institution and the high variability of the genetic hosts of this gene.

ACKNOWLEDGMENTS

This work was supported by the Brazilian funding agencies CNPq, CAPES, FACEPE, and PFA/UPE.

For sequencing of PCR products, we thank the Technological Platform for Genomics and Gene Expression, Centre of Biological Sciences, Federal University of Pernambuco.

Footnotes

Published ahead of print 10 June 2013

REFERENCES

  • 1. Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC. 2009. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob. Agents Chemother. 53:1998–2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Clinical and Laboratory Standards Institute 2012. Performance standards for antimicrobial susceptibility testing; 22nd information supplement. M100-S22-U. Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]
  • 3. Picão RC, Poirel L, Gales AC, Nordmann P. 2009. Diversity of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob. Agents Chemother. 53:3908–3913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall J. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219–228 [DOI] [PubMed] [Google Scholar]
  • 5. Cuzon G, Naas T, Truong H, Villegas MV, Wisell QT, Carmeli Y. 2010. Worldwide diversity of Klebsiella pneumoniae that produces β-lactamase blaKPC-2 gene. Emerg. Infect. Dis. 16:1349–1356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Almeida AC, Cavalcanti FL, Vilela MA, Gales AC, Morais MA, Jr, Morais MM. 2012. Escherichia coli ST502 and Klebsiella pneumoniae ST11 sharing an IncW plasmid harbouring the blaKPC-2 gene in an intensive care unit patient. Int. J. Antimicrob. Agents 40:374–376 [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES